ACDRS 2022 Session 6 - Integrated Product Development, Portfolio Management, and Project Management; Preparing for Transition to the Market

Monday, October 31, 2022 - 10:00 am to Friday, November 4, 2022 - 3:00 pm

This is Session 6 of 6. Must register for the entire 2022 Course and not per session.


  • Portfolio management: principles, challenges, and strategies
  • Role of licensing in portfolio management
  • Project management: principles, challenges, and strategies
  • Judgment under uncertainty
  • Integrated global strategy
  • Turning strategy into plans
  • Co-development and alliances
  • Strategic marketing (commercial) role in development
  • How to launch a new drug successfully into the market
  • Digital transformation and artificial intelligence
  • Prescription drug promotion
  • Promotional committee review simulation
  • Pharmacovigilance
  • Leadership strategies in drug development and regulation

Session 6 Chairperson: Charlie Gombar, PhD, ACDRS Director


Sue Duvall, RN MPA Principal Consultant, Duvall Limited LLC

Charlie T. Gombar, PhD

ACDRS Director

Richard Heaslip, PhD

President and Founder, Programmatic Sciences LLC

Craig H. Mallinckrodt, PhD

Senior Vice President, Statistics, Cortexyme
Mark Noguchi, MBA Senior Vice President and Head, Chugai Partnering, Chugai Pharmaceuticals (Japan)
Christiane Pering, MD Head of Medical Devices & eHealth, Bayer Pharmaceuticals
others to be confirmed